We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

11 hedge funds and large institutions have $10M invested in Tiziana Life Sciences in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

178% more capital invested

Capital invested by funds: $3.6M → $10M (+$6.43M)

38% more funds holding

Funds holding: 811 (+3)

0.16% more ownership

Funds ownership: 1.98%2.14% (+0.16%)

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

TLSA Hedge Fund Activity: Q2 2020 in Review

11 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q2 2020, worth a combined $10M — up 178% from $3.6M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TLSA positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $705K. The largest seller was HighPoint Advisor Group, cutting an estimated $710.

  • 11 institutional investors held Tiziana Life Sciences (TLSA) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $10M of Tiziana Life Sciences stock for Q2 2020, up 178% quarter-over-quarter.
  • 4 funds opened new Tiziana Life Sciences positions in Q2 2020 and 1 closed out, a net change of +3 holders.
  • The largest Tiziana Life Sciences buyer in Q2 2020 was Renaissance Technologies, an estimated $705K added.
  • The largest Tiziana Life Sciences seller in Q2 2020 was HighPoint Advisor Group, an estimated $710 sold.

Based on aggregated 13F filings for Q2 2020.